Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. Estimated Operating Results for the First Half of 2023.pdf Estimated Operating Results for the First Half of 2023

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 23 / 2023
Date of issue: 2023-07-06
Short name of the issuer
KRKA
Subject
Information regarding estimated operating results of the Krka Group for the first half of 2023
Official market - legal basis
art. 17. 1 MAR.
Unofficial market - legal basis
Contents of the report:
Based on Article 17 of Regulation (EU) no. 596/2014 company Krka, d. d., Novo mesto releases information regarding estimated operating results of the Krka Group for the first half of 2023.

See attached document.


The notice will be published on the Company's website (www.krka.biz) from 6 July 2023 onwards, for a period of at least 5 years.
Annexes
File Description
Estimated Operating Results for the First Half of 2023.pdf
Estimated Operating Results for the First Half of 2023.pdf		 Estimated Operating Results for the First Half of 2023

KRKA, TOVARNA ZDRAVIL D.D.
(fullname of the issuer)
KRKA Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
8501 Nove Mesto
(post code) (city)
Smarjeska 6
(street) (number)
+386 7 331 21 11 +386 7 332 15 37
(phone number) (fax)
(e-mail) (web site)
nie dotyczy
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2023-07-06 Jože Colarič President of the Management Board and CEO
20230706_132851_0142028980_Estimated_Operating_Results_for_the_First_Half_of_2023.pdf

Pobierz